Related Experiment Video
Updated: May 19, 2026
05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Inflammation in atherosclerosis
1Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA. plibby@rics.bwh.harvard.edu
Arteriosclerosis, Thrombosis, and Vascular Biology
|August 17, 2012
Summary
Inflammation plays a key role in atherosclerosis development and progression. Understanding inflammatory pathways, including cytokines, offers new insights into arterial disease and potential clinical treatments.
Area of Science:
- Cardiovascular Biology
- Immunology
- Pathophysiology
Background:
- Atherosclerosis is a chronic inflammatory disease.
- Cytokines act as inflammatory messengers, linking risk factors to arterial changes.
- Immune responses contribute to arterial hyperplasia, as seen in allograft arteriosclerosis.
Purpose of the Study:
- To elucidate the molecular and cellular pathways of inflammation in atherosclerosis.
- To understand the role of cytokines in mediating the effects of risk factors on arterial biology.
- To explore how inflammation influences plaque biology and thrombotic complications.
Main Methods:
- Experimental elucidation of molecular and cellular inflammatory pathways.
- Investigation of cytokine roles as inflammatory messengers.
- Analysis of the immune basis of allograft arteriosclerosis.
Main Results:
- Inflammation promotes atherosclerosis through specific molecular and cellular pathways.
- Cytokines mediate the impact of risk factors on arterial biology, creating a pro-atherothrombotic state.
- Inflammation drives arterial hyperplasia independently of traditional risk factors.
Conclusions:
- Understanding inflammation's role in atherosclerosis provides mechanistic insights.
- Translational research has led to clinical advances in managing atherosclerosis.
- Targeting inflammatory pathways offers therapeutic potential for atherosclerosis and its complications.
Related Concept Videos
01:38Inflammation
Overview
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...